Childhood cancer treatment tested on adults in hope for better leukemia control
NCT ID NCT01920737
Summary
This study is testing whether a chemotherapy combination commonly used to treat children with acute lymphoblastic leukemia (ALL) is safe and effective for adults aged 18-60 with newly diagnosed ALL. The goal is to see if this 'pediatric-inspired' approach can help adults achieve deep remission with fewer side effects from certain drugs. Researchers will measure how well the treatment eliminates leukemia cells and monitor patients' survival and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27701, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Weill Cornell Medical Center
New York, New York, United States
Conditions
Explore the condition pages connected to this study.